+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immune Disorders Drugs Market Research Reports

Mucopolysaccharidosis I - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Mucopolysaccharidosis I - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Immune Thrombocytopenia (ITP) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Immune Thrombocytopenia (ITP) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Graft Versus Host Disease (GvHD) - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Graft Versus Host Disease (GvHD) - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD) - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD) - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Chemotherapy Induced Neutropenia (CIN) - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Chemotherapy Induced Neutropenia (CIN) - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Human Immunodeficiency Virus Type-1 (HIV-1) - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Human Immunodeficiency Virus Type-1 (HIV-1) - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Peanut Allergy - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Peanut Allergy - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Adult-onset Still's Disease - Epidemiology Forecast to 2032 - Product Thumbnail Image

Adult-onset Still's Disease - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Lambert-Eaton Myasthenic Syndrome (LEMS) - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Lambert-Eaton Myasthenic Syndrome (LEMS) - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Rheumatoid Arthritis (RA) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Rheumatoid Arthritis (RA) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Sjogren's Syndrome - Epidemiology Forecast to 2032 - Product Thumbnail Image

Sjogren's Syndrome - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Interferon - Biosimilar Insight, 2022 - Product Thumbnail Image

Interferon - Biosimilar Insight, 2022

  • Report
  • January 2022
  • 70 Pages
  • Global
From
Infliximab-Biosimilars Insight, 2022 - Product Thumbnail Image

Infliximab-Biosimilars Insight, 2022

  • Report
  • January 2022
  • 90 Pages
  • Global
From
Adalimumab-Biosimilars Insight, 2022 - Product Thumbnail Image

Adalimumab-Biosimilars Insight, 2022

  • Report
  • January 2022
  • 90 Pages
  • Global
From
Pemphigus Vulgaris (PV)-Epidemiology Forecast - 2032 - Product Thumbnail Image

Pemphigus Vulgaris (PV)-Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Microscopic Polyangiitis (MPA) - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Microscopic Polyangiitis (MPA) - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Microscopic Polyangiitis (MPA)- Epidemiology Forecast to 2032 - Product Thumbnail Image

Microscopic Polyangiitis (MPA)- Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Chronic Rhinosinusitis without Nasal Polyps (CRSsNP) - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Chronic Rhinosinusitis without Nasal Polyps (CRSsNP) - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Chronic Rhinosinusitis without Nasal Polyps - Epidemiology Forecast to 2032 - Product Thumbnail Image

Chronic Rhinosinusitis without Nasal Polyps - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Rheumatoid Arthritis - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Rheumatoid Arthritis - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Loading Indicator

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection. The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more